Author pages are created from data sourced from our academic publisher partnerships and public sources.
Dosing practices and risk factors for bleeding in patients receiving enoxaparin for the treatment of an acute coronary syndrome.
OBJECTIVES To describe dosing practices and to identify risk factors for bleeding in patients with an acute coronary syndrome (ACS) who received treatment with enoxaparin. DESIGN Retrospective… Expand
Islet cell antibodies and antibodies against glutamic acid decarboxylase in newly diagnosed adult-onset diabetes mellitus.
This study aimed to determine the prevalence of antibodies against glutamic acid decarboxylase (anti-GAD) and islet cell antibodies (ICA) in relation to beta-cell function in adults newly-diagnosed… Expand
Temporal Variation in Incidence of IDDM in Canterbury, New Zealand
Objective To establish the statistical significance of observed variations over the last decade in the incidence of insulin-dependent diabetes mellitus (IDDM) in the 0- to 19-yr-old age-group and to… Expand
HLA-DQβ Typing and Non-Asp57 Alleles in IDDM and Nondiabetic Subjects in New Zealand
OBJECTIVE To determine the frequency of IDDM risk-associated HLA-DQβ alleles in New Zealanders with IDDM and nondiabetic control subjects, and to examine these as susceptibility markers in relation… Expand
Immunogenetic, Clinical, and Demographic Characterization of Childhood Type I Diabetes in New Zealand
OBJECTIVE To examine the relationship between genetic susceptibility alleles and islet cell antibodies (ICAs) in type I diabetes. RESEARCH DESIGN AND METHODS The human leukocyte antigen (HLA)-DQB1… Expand
Plasma proinsulin in recently diagnosed type 2 diabetes mellitus.
- R. S. Schmidli, C. Hǎgan, R. Scott, J. Livesey, L. Forbes
- Diabetes research and clinical practice
- 1 May 1993
We measured levels of immunoreactive insulin (IRI) and proinsulin using a sensitive and specific immunoradiometric assay (IRMA), in non-obese recently diagnosed type 2 diabetic subjects. The… Expand